Clinical Trials Sponsored by Hatch Inc

Total 35365 results

Tatch Inc.

Not yet recruiting

Assessing the Performance of Wesper Lab for Sleep Apnea Diagnosis in Pediatric Populations

Sleep Apnea Syndromes | Sleep Apnea | Sleep Apnea Syndromes in Children

United States
Stacey Hatch

Completed

Emotion-Focused Mindfulness Therapy: A Feasibility Study for Late Life Anxiety

Anxiety

Canada
Western University, Canada
InteraXon, Inc.; Cambridge Brain Sciences; Hatch Inc

Not yet recruiting

Assessing the Effects of the Muse Sleep Intervention on Sleep (MuseSleep)

Coaching | Mediation
Swedish Match AB

Completed

Serbian Smoking Reduction/Cessation Trial (2SRT) (2SRT)

Cigarette Smoking

Serbia
George F. Hatch

Recruiting

Oxandrolone Multiligament Knee

Ligament Tear Knee

United States
Swedish Match AB

Completed

Controlled Study of the Ability of a Smokefree Tobacco Product to Increase the Quit Rate Among Cigarette Smokers

Cigarette Smoking

United States
Regenerative Patch Technologies, LLC

Active, not recruiting

Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD

Geographic Atrophy | Dry Macular Degeneration

United States
Paul G. Harch, M.D.
Harch Hyperbaric Research Foundation

Unknown

Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Cerebral Decompression Illness

Cerebral Decompression Illness, All Phases

United States
Paul G. Harch, M.D.
Harch Hyperbaric Research Foundation

Unknown

Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Traumatic Brain Injury

Residual Neurological, Cognitive, Emotional, Behavioral Effects From Traumatic Brain Injury

United States
Paul G. Harch, M.D.
Harch Hyperbaric Research Foundation

Unknown

Hyperbaric Oxygen Therapy and SPECT Brain Imaging in Carbon Monoxide Poisoning

Neuropsychiatric Sequelae of Carbon Monoxide Poisoning

United States
Paul G. Harch, M.D.
Harch Hyperbaric Research Foundation

Unknown

Oxygen Toxicity of HBOT in Chronic Brain Injury

Adult and Pediatric Chronic Cerebral Disorders

United States
Contract Research Organization el AB
Swedish Match AB

Completed

In-vivo Extraction of Lead, Cadmium and Tobacco Specific Nitrosamines From Swedish 'Snus' in Regular Snus Users (SMWS03)

Smoking Cessation | Harm Reduction

Sweden
Contract Research Organization el AB
Swedish Match AB

Completed

In-vivo Extraction of Pb, Cd and TSNA From Swedish Snus (SMWS03)

Smoking Cessation | Harm Reduction | Smokeless Tobacco

Sweden
Contract Research Organization el AB
Swedish Match AB

Completed

4 mg Nicotine Polacrilex Gum and Swedish Portion Snus (SMWS06)

Healthy Subjects | Smokers

Sweden
Contract Research Organization el AB
Swedish Match AB

Completed

In-vivo Extraction of Pb, Cd andTSNA From Swedish Snus (SMWS03)

Smoking Cessation | Harm Reduction | Smokeless Tobacco

Sweden
Massachusetts General Hospital
National Institute of Mental Health (NIMH); Match Research

Completed

Support for Perinatal Adherence and Depression (INSPireD)

Depression | Human Immunodeficiency Virus

United States, South Africa
CONRAD
RTI International; Match Research; UZ-UCSF Collaborative Research Programme

Completed

The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pregnancy

HIV | Contraception

South Africa, Zimbabwe
Karex Industries Sdn. Bhd.
Essential Access Health; Match Research; Sigma3 Services SARL

Recruiting

Evaluation of Synthetic Nitrile Male Condom Compared to Standard Latex Male Condom

Sexually Transmitted Diseases

United States, South Africa
The University of Texas Health Science Center at...
Patch Rx Technologies

Completed

The Impact of Patch Rx Technologies on Adherence to Vitamin and Trikafta Therapies in Patients With Cystic Fibrosis

Cystic Fibrosis | Adherence, Medication

United States
IND Diagnostic Inc.

Unknown

Evaluation of the IND One Step Strep A Rapid Test vs. Culture

Strep Throat

United States
Brigham and Women's Hospital
Centers for Disease Control and Prevention; Harvard Pilgrim Health Care Institute and other collaborators

Recruiting

Pre-emptive Prevention for Patients at High Risk for Hospital-onset Clostridioides Difficile

C. Difficile

United States
MetroHealth Medical Center
Cleveland Metropolitan School District; Environmental Health Watch; Legal Aid...

Completed

Registry and Screening Tool to Identify Children With Asthma Likely to Benefit From Home Assessment and Remediation (CREST)

Asthma | Pediatric ALL | Medical Informatics | Social Determinants of Health | School Health Services | Registries | Home Visits | Housing Problems | Healthcare Disparity | Health Status Disparity

United States
National Institute of Allergy and Infectious Diseases...
University of Maryland, Baltimore; Duke University; HIV Vaccine Trials Network... and other collaborators

Withdrawn

Evaluating the Safety and Immunogenicity of a Prime-boost Vaccine Regimen of GEO-D02 DNA and MVA/HIV62B With and Without B63521^11 gp120 and IHV01 gp120 Env Proteins in Healthy, HIV-uninfected Adult Participants

HIV Infections
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.; Oncoceutics, Inc.

Recruiting

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Metastasis | Endometrial Cancer

United States
NC Medial Research Inc

Recruiting

A Study of NCS-01 in Patients With Acute Ischemic Stroke

Ischemic Stroke

United States
IC-IT Sciences Inc.

Unknown

Comparison of the Natural Frequencies Technology Sleep Patches to Sham Patches During Sleep in the Home Environment

Sleep Disturbance

United States
Zhengzhou Gensciences Inc
Haimen Gensciences lnc

Completed

An Open Label Study to Determine the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A.

Hemophilia A

China
Zhengzhou Gensciences Inc
Jiangsu Gensciences lnc.

Completed

Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A (RH-107-III02)

Hemophilia A

China
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Completed

Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma

Hodgkin Lymphoma, Adult

United States
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Terminated

Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids (NRR)

Graft Versus Host Disease

United States
UNC Lineberger Comprehensive Cancer Center
Veracyte, Inc.

Recruiting

Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA (HARMONY)

Breast Cancer

United States
UNC Lineberger Comprehensive Cancer Center
Seagen Inc.

Active, not recruiting

BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma

Lymphoma | Lymphatic Diseases | Adult T-Cell Leukemia/Lymphoma

United States
IGC Pharma LLC

Completed

Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease

Dementia of Alzheimer Type

Puerto Rico
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Completed

Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation

Hematologic Malignancies | Malignant Solid Tumor

United States
IGC Pharma LLC

Recruiting

IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's (IGC-AD1-P2)

Aggression | Depression | Anxiety | Alzheimer Disease | Memory Impairment | Agitated; State, Acute Reaction to Stress | Agitation,Psychomotor | Care Giving Burden | NPS | Aggressive Outburst

United States, Canada, Puerto Rico
UNC Lineberger Comprehensive Cancer Center
Genentech, Inc.

Recruiting

Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma

Diffuse Large B-cell Lymphoma

United States
Novan, Inc.
Synteract, Inc.; Therapeutics, Inc.

Completed

A Phase 3 Molluscum Contagiosum Efficacy and Safety Study (B-SIMPLE4)

Molluscum Contagiosum

United States
OBELAB, Inc.
Helptrial Inc.

Not yet recruiting

Evaluation of rSO2 Between Frontal Lesion Area and Normal Area of Brain by NIRSITX Using NIRS in Acute Ischemic Stroke Patients.

Acute Ischemic Stroke Patients

Korea, Republic of
Athersys, Inc
Medpace, Inc.

Recruiting

MultiStem® Administration for Stroke Treatment and Enhanced Recovery Study (MASTERS-2)

Ischemic Stroke

United States, Taiwan
89bio, Inc.
ProSciento, Inc.

Completed

A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH

NASH

United States, Puerto Rico
ModernaTX, Inc.
Aetion, Inc.

Active, not recruiting

Post-marketing Safety of Elasomeran/Davesomeran and Andusomeran

SARS-CoV-2

United States
Eisai Inc.
Quintiles, Inc.

Terminated

FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer

Colorectal Cancer

United States, Australia, Russian Federation, India, Ukraine
AxeroVision, Inc.
ORA, Inc.

Completed

A Study to Evaluate AXR-159 Ophthalmic Solution in Patients With Dry Eye Disease

Dry Eye

United States
Versartis Inc.

Completed

Long-Acting Growth Hormone in Children Compared to Daily rhGH (VELOCITY)

Growth Disorders
Novan, Inc.
Synteract, Inc.

Completed

A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1)

Molluscum Contagiosum

United States
EmitBio Inc.

Completed

Phase I/II Safety, Dose Finding & Antiviral Activity of RD-X19 in Mild/Moderate Outpatient COVID-19

COVID19

United States
Xoft, Inc.
Icad, Inc.

Withdrawn

An Efficacy Study of the Xoft® Axxent® eBx® IORT System® "Lite"

Ductal Carcinoma In Situ | Invasive Ductal Carcinoma
Versartis Inc.

Completed

Versartis Trial in Children to Assess Long-Acting Growth Hormone (VERTICAL)

Pediatric Growth Hormone Deficiency

United States
EmitBio Inc.

Completed

Evaluation of the RD-X19 Treatment Device in Individuals With Mild to Moderate COVID-19

COVID19

United States
Mylan Inc.

Completed

Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules

Cystic Fibrosis

United States

Clinical Trials Sponsored by Hatch Inc

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations